Studies on Missense Changes and Unclassified Variants in BRCA1 and
BRCA2
This table was generated from our database on 15-03-2002. We will continue to add references to this database and post updates on this site regularly.
|
Gene |
Exon |
Nucleotide |
Base Change |
Codon |
AA Change |
Designation |
Reference |
|
BRCA1 |
2 |
151 |
T to C |
11 |
Val to Ala |
V11A |
(7)
|
|
BRCA1 |
2 |
172 |
T to C |
18 |
Met to Thr |
M18T |
(7)
|
|
BRCA1 |
2 |
180 |
A to G |
21 |
Ile to Val |
I21V |
(7)
|
|
BRCA1 |
2 |
189 |
T to C |
24 |
Cys to Arg |
C24R |
(7)
|
|
BRCA1 |
3 |
212 |
C to G |
31 |
Ile to Met |
I31M |
(7)
|
|
BRCA1 |
3 |
229 |
C to G |
37 |
Thr to Arg |
T37R |
(7)
|
|
BRCA1 |
3 |
234 |
TG to GC |
39 |
Cys to Ala |
C39A |
(1)
|
|
BRCA1 |
3 |
235 |
G to A |
39 |
Cys to Tyr |
C39Y |
(7)
|
|
BRCA1 |
3 |
240 |
CA to GC |
41 |
His to Ala |
H41A |
(1)
|
|
BRCA1 |
3 |
243 |
A to G |
42 |
Ile to Val |
I42V |
(7)
|
|
BRCA1 |
5 |
270 |
CT to GC |
51 |
Leu to Ala |
L51A |
(7)
|
|
BRCA1 |
5 |
300 |
T to G |
61 |
Cys to Gly |
C61G |
(1)
|
|
BRCA1 |
5 |
300 |
T to G |
61 |
Cys to Gly |
C61G |
(7)
|
|
BRCA1 |
5 |
300 |
TG to GC |
61 |
Cys to Ala |
C61A |
(1)
|
|
BRCA1 |
5 |
300 |
T to G |
61 |
Cys to Gly |
C61G |
(9)
|
|
BRCA1 |
5 |
309 |
TG to GC |
64 |
Cys to Ala |
C64A |
(1)
|
|
BRCA1 |
5 |
310 |
G to A |
64 |
Cys to Tyr |
C64Y |
(7)
|
|
BRCA1 |
5 |
330 |
A to G |
71 |
Arg to Gly |
R71G |
(7)
|
|
BRCA1 |
16 |
4801 |
C to T |
1561 |
Thr to Ile |
T1561I |
(5)
|
|
BRCA1 |
16 |
4810 |
T to C |
1564 |
Leu to Pro |
L1564P |
(5)
|
|
BRCA1 |
16 |
5029 |
C to T |
1637 |
Pro to Leu |
P1637L |
(4)
|
|
BRCA1 |
18 |
5208 |
T to C |
1697 |
Cys to Arg |
C1697R |
(8)
|
|
BRCA1 |
18 |
5214 |
C to T |
1699 |
Arg to Trp |
R1699W |
(8)
|
|
BRCA1 |
18 |
5215 |
G to T |
1699 |
Arg to Leu |
R1699L |
(8)
|
|
BRCA1 |
18 |
5236 |
G to A |
1706 |
Gly to Glu |
G1706E |
(8)
|
|
BRCA1 |
18 |
5242 |
C to A |
1708 |
Ala to Glu |
A1708E |
(4)
|
|
BRCA1 |
18 |
5242 |
C to A |
1708 |
Ala to Glu |
A1708E |
(8)
|
|
BRCA1 |
18 |
5242 |
C to A |
1708 |
Ala to Glu |
A1708E |
(9)
|
|
BRCA1 |
18 |
5264 |
C to A |
1715 |
Ser to Arg |
S1715R (5264C>A) |
(8)
|
|
BRCA1 |
18 |
5273 |
G to T |
1718 |
Trp to Cys |
W1718C |
(8)
|
|
BRCA1 |
20 |
5317 |
A to G |
1733 |
Asp to Gly |
D1733G |
(5)
|
|
BRCA1 |
20 |
5332 |
G to A |
1738 |
Gly to Glu |
G1738E |
(5)
|
|
BRCA1 |
21 |
5443 |
T to G |
1775 |
Met to Arg |
M1775R |
(8)
|
|
BRCA1 |
21 |
5443 |
T to G |
1775 |
Met to Arg |
M1775R |
(6)
|
|
BRCA1 |
21 |
5443 |
T to G |
1775 |
Met to Arg |
M1775R |
(4)
|
|
BRCA1 |
23 |
5535 |
C to G |
1806 |
Pro to Ala |
P1806A |
(5)
|
|
BRCA1 |
24 |
5628 |
T to C |
1837 |
Trp to Arg |
W1837R |
(8)
|
|
BRCA1 |
24 |
5628 |
T to C |
1837 |
Trp to Arg |
W1837G |
(8)
|
|
BRCA2 |
11 |
4486 |
G to T |
1420 |
Asp to Tyr |
D1420Y (G>T) |
(3)
|
|
BRCA2 |
11 |
4516 |
A to G |
1430 |
Thr to Ala |
T1430A |
(3)
|
|
BRCA2 |
11 |
4813 |
G to A |
1529 |
Gly to Arg |
G1529R |
(2)
|
References
1.
Brzovic PS, Meza JE, King MC, Klevit RE (2001) BRCA1 RING domain
cancer-predisposing mutations - Structural consequences and effects on
protein-protein interactions. J Biol Chem, 276: 41399-41406.
2.
Chen CF, Chen PL, Zhong Q, Sharp ZD, Lee WH (1999) Expression of BRC
repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to
radiation hypersensitivity and loss of G(2)/M checkpoint control. J Biol Chem,
274: 32931-32935.
3.
Davies AA, Masson JY, Mcllwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman
AR, West SC (2001) Role of BRCA2 in control of the RAD51 recombination and DNA
repair protein. Mol Cell, 7: 273-282.
4.
Futreal P, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S,
Bennett L, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C,
Weaver-Feldhaus J, Ding W, Gholami Z, Soederkvist P, Terry L, Jhanwar S,
Berchuck A, Iglehart J, Marks J, Ballinger D, Barrett J, Skolnick M, Kamb A,
Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science,
266: 120-122.
5.
Hayes F, Cayanan C, Barilla D, Monteiro ANA (2000) Functional assay for
BRCA1: Mutagenesis of the COOH- terminal region reveals critical residues for
transcription activation. Cancer Res, 60: 2411-2418.
6.
Miki Y, Swensen J, Shattuck-Eidens D, Futreal P, Harshman K, Tavtigian S,
Liu Q, Cochran C, Bennett L, Ding W, Bell R, Rosenthal J, Hussey C, Tran T,
McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K,
Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J,
Tonin P, Narod S, Bristow P, Norris F, Meera Khan P, Morrison P, Rosteck P, Lai
M, Barrett J, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar R, Kamb A,
Wiseman R, Skolnick M (1994) A strong candidate for the breast and ovarian
cancer susceptibility gene BRCA1. Science, 266: 66-71.
7.
Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM (2001)
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin
protein ligase activity and protection from radiation hypersensitivity. Proc
Natl Acad Sci USA, 98: 5134-5139.
8.
Williams RS, Green R, Glover JNM (2001) Crystal structure of the BRCT
repeat region from the breast cancer-associated protein BRCA1. Nature Struct
Biol, 8: 838-842.
9.
Zhong Q, Chen CF, Li S, Chen YM, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee
WH (1999) Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA
damage response. Science, 285: 747-750.